Press Releases :: VolitionRx Ltd (VNRX)

Apr 11, 2017 7:00 am EDT

VolitionRx Appoints David Vanston as Chief Financial Officer

Mar 28, 2017 4:01 pm EDT

Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

Mar 20, 2017 6:30 am EDT

VolitionRx Limited Announces the Formation of Volition America, Inc.

Mar 14, 2017 1:56 pm EDT

VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange

Mar 13, 2017 6:30 am EDT

VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time

Mar 10, 2017 6:30 am EST

VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update

Mar 8, 2017 6:30 am EST

VolitionRx Limited to Present at the 29th Annual ROTH Conference

Mar 6, 2017 5:00 pm EST

VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update

Mar 2, 2017 6:30 am EST

A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark

Feb 24, 2017 6:30 am EST

VolitionRx Limited's Triage Test Results Validated in Prospective Trial

rss_feed News RSS